259 related articles for article (PubMed ID: 18413137)
1. Collaborative study for the establishment of erythropoietin BRP batch 3.
Behr-Gross ME; Daas A; Burns C; Bristow AF
Pharmeuropa Bio; 2007 Dec; 2007(1):49-66. PubMed ID: 18413137
[TBL] [Abstract][Full Text] [Related]
2. Collaborative study for the establishment of erythropoietin BRP batch 2.
Behr-Gross ME; Daas A; Bristow AF
Pharmeuropa Bio; 2004 Dec; 2004(1):23-33. PubMed ID: 15659283
[TBL] [Abstract][Full Text] [Related]
3. Collaborative study for the establishment of erythropoietin BRP batch 4.
Burns C; Bristow AF; Daas A; Costanzo A
Pharmeur Bio Sci Notes; 2015; 2015():246-53. PubMed ID: 26830170
[TBL] [Abstract][Full Text] [Related]
4. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
[TBL] [Abstract][Full Text] [Related]
5. Collaborative study for the establishment of erythropoietin BRP batch 5.
Ferguson J; Burns CJ; Regourd E; Costanzo A
Pharmeur Bio Sci Notes; 2019; 2019():27-33. PubMed ID: 30880683
[TBL] [Abstract][Full Text] [Related]
6. Establishment of Ph. Eur. Bordetella pertussis mouse antiserum Biological Reference Preparation batches 2, 3 and 4.
Morgeaux S; Chagnaud P; Variot P; Le Tallec D; Behr-Gross ME
Pharmeur Bio Sci Notes; 2020; 2020():161-202. PubMed ID: 32788038
[TBL] [Abstract][Full Text] [Related]
7. European Pharmacopoeia biological reference preparation for poliomyelitis vaccine (inactivated): collaborative study for the establishment of batch No. 3.
Martin J; Daas A; Milne C
Pharmeur Bio Sci Notes; 2016; 2016():135-150. PubMed ID: 28279255
[TBL] [Abstract][Full Text] [Related]
8. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
[TBL] [Abstract][Full Text] [Related]
9. Establishment of the Ph. Eur. erythropoietin chemical reference substance batch 1.
Burns C; Bristow AF; Buchheit KH; Daas A; Wierer M; Costanzo A
Pharmeur Bio Sci Notes; 2015; 2015():99-117. PubMed ID: 26830161
[TBL] [Abstract][Full Text] [Related]
10. Calibration of human coagulation factor VII concentrate Ph. Eur. BRP batch 2.
Dodt J; Costanzo A; Daas A; Hunfeld A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):31-8. PubMed ID: 20223188
[TBL] [Abstract][Full Text] [Related]
11. Establishment of European Pharmacopoeia BRP batch 2 for inactivated poliomyelitis vaccine for in vitro D antigen assay.
Fuchs F; Minor P; Daas A; Milne C
Pharmeuropa Bio; 2003 Jul; 2003(1):23-50. PubMed ID: 14563307
[TBL] [Abstract][Full Text] [Related]
12. Calibration of European pharmacopoeia biological reference preparation for diphtheria vaccine (adsorbed) batch 4.
Stickings P; Rigsby P; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):1-9. PubMed ID: 20144448
[TBL] [Abstract][Full Text] [Related]
13. Establishment of European Pharmacopoeia (Ph. Eur.) Biological Reference Preparations (BRP) batch 2 for rDNA hepatitis B vaccine (method A and B).
Dobbelaer R; Daas A; Milne C
Pharmeuropa Bio; 2004 Jan; 2003(2):77-90. PubMed ID: 14960264
[TBL] [Abstract][Full Text] [Related]
14. Collaborative study for the establishment of the Ph. Eur. BRP batch 1 for anti-vaccinia immunoglobulin.
Fuchs F; Poirier B; Leparc-Goffart I; Buchheit KH
Pharmeuropa Bio; 2005 Sep; 2005(1):13-8. PubMed ID: 16336934
[TBL] [Abstract][Full Text] [Related]
15. Collaborative study for the calibration of the Ph. Eur. prekallikrein activator in albumin BRP batches 4, 5 and 6.
Lackner F; Daas A; Terao E
Pharmeur Bio Sci Notes; 2015; 2015():1-10. PubMed ID: 26830155
[TBL] [Abstract][Full Text] [Related]
16. Calibration of human coagulation factor VIII concentrate Ph. Eur. BRP Batch 4 for use in potency assays.
Raut S; Costanzo A; Daniels S; Heath A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):1-29. PubMed ID: 21144486
[TBL] [Abstract][Full Text] [Related]
17. Collaborative study for the establishment of replacement batches of heparin low- molecular-mass for assay biological reference preparations.
Terao E; Daas A; Rautmann G; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):30-6. PubMed ID: 21144487
[TBL] [Abstract][Full Text] [Related]
18. Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.
Kirschbaum N; Wood L; Lachenbruch P; Weinstein M; Daas A; Rautmann G; Spieser JM; Buchheit KH
Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):31-64. PubMed ID: 12448031
[TBL] [Abstract][Full Text] [Related]
19. Establishment of the European Pharmacopoeia Biological Reference Preparation (Ph. Eur. BRP) for hepatitis A vaccine type B (Aventis Pasteur) batch 2.
Buchheit KH; Daas A
Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):95-108. PubMed ID: 12448033
[TBL] [Abstract][Full Text] [Related]
20. Establishment of replacement batches for prekallikrein activator in albumin biological reference preparation.
Lackner F; Daas A; Terao E; Behr-Gross ME
Pharmeuropa Bio; 2008 Dec; 2008(1):1-6. PubMed ID: 19220976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]